Timely Hepatitis C RNA Testing and Treatment in the Era of Direct-Acting Antiviral Therapy among People with Hepatitis C in New South Wales, Australia

Timely Hepatitis C RNA Testing and Treatment in the Era of Direct-Acting Antiviral Therapy among People with Hepatitis C in New South Wales, Australia

This study aimed to identify the factors associated with timely (within four weeks) HCV RNA testing and timely (within six months) DAA initiation following HCV notification in the DAA era. We conducted a cohort study of people with an HCV notification in NSW, Australia. Notifications of positive HCV...

Full description

Bibliographic Details
Main Authors: Mohammad T. Yousafzai, Maryam Alavi, Heather Valerio, Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Viruses
Subjects:
hepatitis C virus
direct acting antiviral therapy
HCV RNA testing
treatment uptake
data linkage
Online Access:https://www.mdpi.com/1999-4915/14/7/1496

Internet

https://www.mdpi.com/1999-4915/14/7/1496

Similar Items